English
Dr Reddy's Laboratories Q2 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,277.40
-2.25 (-0.18%)
-2.25 (-0.18%)Volume73.18 K
Updated: Mon 15 Dec, 2025 | 15:29:45
NSE
1,280.60
1.30 (0.10%)
1.30 (0.10%)Volume1.08 M
Updated: Mon 15 Dec, 2025 | 15:43:37
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹8,828.30 Cr.(9.83%)
- Operating Profit₹1,505.30 Cr.(-10.37%)
- Profit After Tax₹1,347.10 Cr.(7.28%)
- Operating Margin17.05%(-18.39%)
Note: Comparison is on YoY basis
Quarterly - Dr Reddy's Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 7,323.00 | 6,874.60 | 6.52% | 6,358.70 | 15.17% |
| Depreciation/ Amortization | 504.60 | 476.10 | 5.99% | 397.00 | 27.10% |
| Operating Income | 1,505.30 | 1,697.50 | -11.32% | 1,679.50 | -10.37% |
| Net Income | 1,347.10 | 1,418.10 | -5.01% | 1,255.70 | 7.28% |
| Other Operating Expenses Total | 2,175.30 | 2,087.50 | 4.21% | - | N/A |
| Net Income Before Taxes | 1,744.80 | 1,905.00 | -8.41% | 1,917.40 | -9.00% |
| Total Revenue | 8,828.30 | 8,572.10 | 2.99% | 8,038.20 | 9.83% |
| Selling/ General/ Admin Expenses Total | 1,452.10 | 1,503.50 | -3.42% | 3,502.60 | -58.54% |
| Diluted Normalized EPS | 16.79 | 17.02 | -1.36% | 15.85 | 5.92% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.